CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris

International Journal of Immunogenetics

Volumn 33, Issue 3, 2006, Pages 217-224

  Luszczek W ^a   Kubicka, W ^b   Jasek, M ^a   Baran, E ^b   Cislo M ^b   Nockowski, P ^b   Luczywo Rudy M ^c   Wisniewski A ^a   Nowak, I ^a   Kusnierczyk P ^a,d  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Regional Centre of Blood Transfusion   (Poland)

^d University of Jan D ugosz   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC SIMILARITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL DISTRIBUTION;

ADULT; AGED; ALLELES; ALTERNATIVE SPLICING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROTEIN ISOFORMS; PSORIASIS; RECOMBINANT PROTEINS;

EID: 33646878291     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2006.00600.x     Document Type: Article

References (53)

1. Abrams, J.R., Kelley, S.L., Hayes, E., Kikuchi, T., Brown, M.J., Kang, S. et al. 2000 Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. Journal of Experimental Medicine, 192, 681.
2. Abrams, J.R., Lebwohl, M.G., Guzzo, C.A., Jegasothy, B.V., Goldfarb, M.T., Goffe, B.S. et al. 1999 CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. Journal of Clinical Investigation, 103, 1243.
3. Ameen, M. 2003 Genetic basis of psoriasis vulgaris and its pharmacogenetic potential. Pharmacogenomics, 4, 297.
4. Anjos, S., N'guyen, A., Ounissi-Benkalha, H., Tessier, M.C. Polychronakos, C. 2002 A common autoimmunity predis- posing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. Journal of Biological Chemistry, 277, 46478.
5. Barker, J.N.W.N. 2001 Genetic aspects of psoriasis. Clinical and Experimental Dermatology, 26, 321.
6. van Belzen, M.J., Mulder, C.J., Zhernakova, A., Pearson, P.L., Houwen, R.H. Wijmenga, C. 2004 CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. European Journal of Human Genetics, 12, 782.
7. Bluestone, J.A. 2005 CTLA-4Ig is finally making it: a personal perspective. American Journal of Transplantation, 5, 423.
8. Boćko, D., Bilińska, M., Dobosz, T., Żoł ȩdziewska, M., Suwalska, K., Tutak, A., Gruszka, E. Frydecka, I. 2003 Lack of association between an exon 1 CTLA-4 gene polymorphism A (49) G and multiple sclerosis in a Polish population of the Lower Silesia region. Archivum Immunologiae et Therapiae Experimentalis, 51, 201.
9. Cisło, M., Hałasa, J., Wa̧sik, F., Nockowski, P., Prussak, M., Mańczak, M. Kuśnierczyk, P. 2002 Allelic distribution of complement components BF, C4A, C4B, and C3 in Psoriasis vulgaris. Immunology Letters, 80, 145.
10. Elder, J.T., Nair, R.P., Henseler, T., Jenisch, S., Stuart, P., Chia, N., Christophers, E. Voorhees, J.J. 2001 The genetics of psoriasis 2001. The Odyssey continues. Archives of Dermatology, 137, 1447.
11. Enerback, C., Enlund, F., Incrot, A., Samuelsson, L., Wahltrom, J., Swanbeck, G. Martinsson, T. 2000 S gene (corneodesmosin) diversity and its relationship to psoriasis: high content of cSNP in the HLA-linked S gene. Journal of Investigative Dermatology, 114, 1158.
12. Fredriksson, T. Petersson, U. 1978 Severe psoriasis: oral therapy with a new retinoid. Dermatologica, 157, 238.
13. Greenwald, R.J., Freeman, G.J. Sharpe, A.H. 2005 The B7 family revisited. Annual Review of Immunology, 23, 515.
14. Gudjonsson, J.E., Johnston, A., Sigmundsdottir, H. Valdimarsson, H. 2004 Immunopathogenic mechanisms in psoriasis. Clinical and Experimental Immunology, 135, 1.
15. Harbo, H.F., Gulowsen, C.E., Vartdal, F. Spurkland, A. 1999 CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens, 53, 106.
16. Heinzmann, A., Plesnar, C., Kuehr, J., Forster, J. Deichmann, K.A. 2000 Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy. European Journal of Immunogenetics, 27, 57.
17. Hizawa, N., Yamaguchi, E., Jinushi, E., Konno, S., Kawakami, Y. Nishimura, M. 2001 Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B. Journal of Allergy and Clinical Immunology, 108, 74.
18. Howard, J., Gordon, C., Allahabadia, A., Barnett, A.H., Franklyn, J.A. Gough, S.C. 1999 The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Annals of Rheumatic Diseases, 58, 193.
19. Ishihara, M., Yamagata, N., Ohno, S., Naruse, T., Ando, A., Kawata, H., Ozawa, A., Ohkido, M., Mizuki, N., Shiina, T., Ando, H. Inoko, H. 1996 Genetic polymorphisms in the keratin-like S gene within the human major histocompatibility complex and association analysis on the susceptibility to psoriasis vulgaris. Tissue Antigens, 48, 182.
20. Kantarci, O.H., Hebrink, D.D., Aschenbach, S.J., Atkinson, E.J., Waliszewska, A., Buckle, G., McMurray, C.T., de Andrade, M., Hafler, D.A. Weinshenker, B.G. 2003 CTLA4 is associated with susceptibility to multiple sclerosis. Journal of Neur oimmunology, 134, 133.
21. Kim, Y.-K., Pyo, C.-W., Hur, S.-S., Kim, T.-Y. Kim, T.-G. 2003 No associations of CTLA-4 and ICAM-1 polymorphisms with psoriasis in the Korean population. Journal of Dermatological Science, 33, 75.
22. Kouki, T., Sawai, Y., Gardine, C.A., Fisfalen, M.E., Alegre, M.L. DeGroot, L.J. 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology, 165, 6606.
23. Kristiansen, O.P., Larsen, Z.M. Pociot, F. 2000 CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes and Immunity, 1, 170.
24. Krueger, J.G. Bowcock, A. 2005 Psoriasis pathophysiology: current concepts of pathogenesis. Annals of the Rheumatic Diseases, 64 Suppl. II ii30.
25. Leibson, P.J. 2004 The regulation of lymphocyte activation by inhibitory receptors. Current Opinion in Immunology, 16, 328.
26. Liu, M.F., Wang, C.R., Chen, P.C. Fung, L.L. 2003 Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scandinavian Journal of Immunology, 57, 568.
27. Luszczek, W., Manczak, M., Cislo, M., Nockowski, P., Wisniewski, A., Jasek, M. Kuśnierczyk, P. 2004 Gene for the activating natural killer cell receptor, KJR2DS1, is associated with susceptibility to psoriasis vulgaris. Human Immunology, 65, 758.
28. Magistrelli, G., Jeannin, P., Herbault, N., Benoit De Cognac, A., Gauchat, J.F., Bonnefoy, J.Y. Delneste, Y. 1999 A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. European Journal of Immunology, 29, 3596.
29. Martin-Pagola, A., Perez de Nanclares, G., Victoria, J.C., Bilbao, J.R., Ortiz, L., Zubillaga, P. Castano, L. 2003 No association of CTLA4 gene with celiac disease in the Basque population. Journal of Pediatric Gastroenterology, 37, 142.
30. Nakagawa, H., Akazaki, S., Asahina, A., Tokunaga, K., Matsuki, K., Kuwata, S., Ishibashi, Y. Juji, T. 1991 Study of HLA class I, class II and complement genes (C2, C4A, C4B, and BF) in Japanese psoriatics and analysis of a newly found high-risk haplotype by pulsed field gel electrophoresis. Archives of Dermatological Research, 283, 281.
31. Nickoloff, B.J. Nestle, F.O. 2004 Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. Journal of Clinical Investigation, 113, 1664.
32. Oaks, M.K. Hallett, K.M. 2000 Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. Journal of Immunology, 164, 5015.
33. Oaks, M.K., Hallett, K.M., Penwell, R.T., Stauber, E.C., Warren, S.J. Tector, A.J. 2000 A native soluble form of CTLA-4. Cellular Immunology, 201, 144.
34. Popat, S., Hearle, N., Hogberg, L., Braegger, C.P., O'Donoghue, D., Falth-Magnusson, K. et al. 2002 Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Annals of Human Genetics, 66, 125.
35. Qin, X.J., Shi, H.Z., Qin, S.M., Kang, L.F., Huang, C.P. Zhong, X.N. 2005 Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics. Allergy, 60, 774.
36. de Rie, M.A., Goedkoop, A.Y. Bos, J.D. 2004 Overview of psoriasis. Dermatologic Therapy, 17, 341.
37. Riley, J.L. June, C.H. 2005 The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood, 105, 13.
38. Sato, S., Fujimoto, M., Hasegawa, M., Komura, K., Yanaba, K., Hayakawa, I., Matsuhita, T. Takehara, K. 2004 Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology (Oxford), 43, 1261.
39. Shevach, E.M., McHugh, R.S., Piccirillo, C.A. Thornton, A.M. 2001 Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunology Review, 182, 58.
40. Shi, Y.Y. He, L. 2005 shesis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research, 15, 97.
41. Shi, H.Z., Mo, X.Y. Zhong, X.N. 2005 Soluble CTLA-4 in sera of patients with bronchial asthma. Journal of Asthma, 42, 133.
42. Stephens, L.A., Mottet, C., Mason, D. Powrie, F. 2001 Human CD4 (+) CD25 (+) thymocytes and peripheral T cells have Immune suppressive activity in vitro. European Journal of Immunology, 31, 1247.
43. Suppiah, V., Alloza, I., Heggarty, S., Goris, A., Dubois, B., Carton, H. Vandenbroeck, K. 2005 The CTLA4 +49 A/G* G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders. Journal of Neuroimmunology, 145, 148.
44. Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T. Muto, M. 2004 Genetic polymorphisms of killer cell immunoglobulin like receptors are associated with susceptibility to psoriasis vulgaris. Journal of Investigative Dermatology, 122, 1133.
45. Tazi-Ahnini, R., Camp, N.J., Cork, M.J., Mee, J.B., Keohane, S.G., Duff, G.W. Giovine, F.S. 1999 Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Human Molecular Genetics, 8, 1135.
46. Tomer, Y., Greenberg, D.A., Barbesino, G., Concepcion, E. Davies, T. 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. Journal of Clinical Endocrinology and Metabolism, 86, 1687.
47. Tsunemi, Y., Saeki, H., Kishimoto, M., Tada, Y., Torii, H., Komine, M., Asahina, A. Tamaki, K. 2003 Cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms in Japanese patients with psoriasis vulgaris. Journal of Dermatological Science, 32, 163.
48. Ueda, H., Howson, J.M.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., Rainbow, D.B., Hunter, K.M., Smith, A.N. Di Genova, G. 2003 43 al.Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 6939.
49. Veale, D.J., Ritchlin, C. FitzGerald, O. 2005 Immunopathology of psoriasis and psoriatic arthritis. Annals of the Rheumatic Diseases, 64 Suppl. II ii26 ii29.
50. Wang, X.-B., Kakoulidou, M., Giscombe, R., Qiu, Q., Huang, D.R., Pirskanen, R. Lefvert, A.K. 2002 Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. Journal of Neuroimmunology, 130, 224.
51. Whyatt, R.J., Wang, C., Hudson, E.C., MacNeeley Jones, R., Noah, P.W. Rosenberg, E.W. 1989 Complement phenotypes in patients with psoriasis. Human Heredity, 39, 327.
52. Wijmenga, C. 2004 CTLA4 +49 and CT60 polymorphisms in Dutch coeliac disease patients. European Journal of Human Genetics, 12, 782.
53. Wong, C.K., Lun, S.W., Ko, F.W., Ip, W.K., Hui, D.S. Lam, C.W. 2005 Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma. Cinical and Experimental Immunology, 141, 122.